Echolight provides Radiofrequency Echographic Multi Spectometry (REMS) technology, an ultrasound-based bone density scan that is an alternative to DXA scans. This technology is portable, with no lead-lined room required and is a better choice for pregnant patients as well as pediatric and oncology patients for monitoring bone health. See a demonstration in our booth. Echolight is headquartered in Italy and in 2020, opened offices in the United States. In less than three years, Echolight built a sales network with more than 40 distributors and several hundreds of customers across the world who have adopted the innovative R.E.M.S. technology for assessing the bone condition of their patients using ultrasound technology.
CurveBeam AI
CurveBeam AI’s orthopedic CT systems scan the patient in a functional position for improved deformity evaluation and treatment planning. The HiRise offers custom protocols compatible with vendor joint replacement planning systems. Compared to conventional full body CT imaging, the CurveBeam AI HiRise is less expensive to operate and maintain. Its infrastructure requirements make it practical for the outpatient setting. Scans are billed via standard CPT codes for CT imaging. | CurveBeam AI’s weight bearing CT systems scan the patient while they stand, making it possible to assess functional alignment in three dimensions. The HiRise, CurveBeam AI’s third-generation weight bearing CT system, is a multifunctional solution that can scan the entire lower extremities, including the hip and pelvis. The HiRise offers the largest patient platform in its class and an unprecedented 40 cm diameter field of view. The HiRise gantry tilts 90 degrees for ergonomic upper extremity imaging, as well as supine imaging of the knees and feet. Compared to conventional full body CT imaging, the CurveBeam AI HiRise is less expensive to maintain and operate. Its compact size and infrastructure requirements make it practical for the outpatient setting, including orthopedic clinics. Scans are billed via CPT codes 73700 – CT Lower Extremity and 73200 – CT Upper Extremity.
Cortechs.ai
Cortechs.ai develops and markets cutting-edge imaging solutions that are used by radiologists, neurologists, and oncologists in hundreds of clinics and research centers around the world. The Cortechs.ai team includes scientists, engineers, business professionals, and clinical specialists working towards the common goal of improving the diagnosis and treatment of patients with neurodegenerative disorders and cancers. Cortechs.ai’s flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice. As the first FDA cleared and CE marked medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant® brings sophisticated, accurate, and fully automated MRI post-processing capabilities. This provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify atrophy of brain structures to help diagnose a variety of brain disorders, including conditions such as Alzheimer’s disease, multiple sclerosis, epilepsy and traumatic brain injury.
Coreline Soft
Coreline Soft is a leading medical AI company specializing in automated thoracic imaging analysis. Its flagship platform, AVIEW, provides a comprehensive suite of AI-powered tools for lung cancer screening, COPD, coronary calcium scoring, and other chest CT applications. The company’s AI solutions are clinically validated and deployed in national screening programs across multiple countries, supporting radiologists with standardized, efficient, and scalable workflows. Coreline’s mission is to empower healthcare providers to detect, quantify, and manage thoracic diseases earlier and more effectively through cutting-edge AI technology and seamless PACS integration.
Convergent Imaging Solutions
Based in Ottawa, Canada, Convergent Imaging Solutions has been a leading vendor of nuclear medicine processing software since 2007. Products include an advanced and highly configurable PET/CT image fusion solution, planar nuclear medicine processing (renal with GFR, motion correction and curve fitting, gastric including GERD, static, dynamic, thyroid, salivary, 2D/3D lung, 2D/3D image subtraction) and radiopharmaceutical dosimetry. PACS integrations include Intelerad, Optum, Agfa, Carestream and Lifetrack, and reseller relationships with Cedars Sinai for its Cardiac Suite and Syntermed for NeuroQ brain uptake quantification.
ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X -ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. Building on more than 40 years of leadership in medical image enhancement, ContextVision is advancing its legacy through the transformation to Data Quality— a focused ultrasound program that leverages AI-powered image-enhancements to enable organ and disease specific quantitative imaging solutions to point-of-care ultrasound. The goal is to deliver a more rapid and accurate detection as well as staging of chronic conditions, such as MASLD (Metabolic dysfunction-associated steatotic liver disease). By combining organ-specific image enhancement, user-independent workflows, as well as quantitative disease-specific digital biomarkers, the platform is being built to support near-patient diagnostic solutions.
ClariPi Inc
ClariPi is an AI company that offers innovative medical imaging solutions through deep-learning and AI technology to change the standards of patient safety, making it our number one priority to reduce harmful health risks. Our products help patients get CT scans with radiation dose at virtually harmless level (1/10th of current practice) and yet produces high-quality images for diagnosis. [Our Key Products] * ClariCT.AI: provides powerful denoising and image clarity enabled by our signature AI-powered clarity engine. This solution works with any CT scanner and PAC system which also can be paired with low-dose and ultra-low-dose CT scans. * ClariPulmo: a fully automated AI-powered 3D reporting solution for emphysema and COVID-19 pneumonia. Our powerful pre-trained deep learning model provides accurate quantitative analysis of lung nodules as well as low-attenuation and high-attenuation lesions despite strong image noise and varying scanning conditions. It is best suited for low-dose lung CT screenings. Ask us how this product can help with COVID-19. * ClariSIGMAM: a fully automated zero-click breast density assessment solution that provides accurate and consistent density estimates from standard digital mammograms. * ClariOsteo: an AI-powered precision bone healthcare solution with low-dose CT images. It uses existing CT scans and automatically provides analysis reports on spine fractures and osteoporosis risks which is useful for prevention and treatment management. * ClariACE: an AI-powered augmented contrast enhancing solution for low-dose CECT images. Our powerful pre-trained deep learning model selectively boosts contrast agent components in CT images without increasing contrast agent doses for patients. It clearly and selectively enhances the contrast of iodine without increasing noise in CT images. Our representative can give you a quick demo of these products as well as detailed image comparisons if you are interested. Thank you!
Circle Cardiovascular Imaging
Circle Cardiovascular Imaging Inc. is a prominent global cardiac imaging company providing AI-based multi-modality reading and reporting solutions for cardiac MR, cardiac CT, vascular CT, cardiac Interventional Planning, and Electrophysiology. Annually, millions of cardiac exams in over 90 countries are interpreted using Circle CVI’s imaging platform, cvi42, giving physicians the tools to accurately quantify and diagnose complex cardiovascular diseases while improving patient outcomes and the effective utilization of healthcare resources. | Circle Cardiovascular Imaging (Circle) delivers advanced software for cardiac and vascular imaging. Our flagship platform, cvi42, empowers clinicians with precise analysis and reporting for MR and CT scans. Trusted by 1,700+ hospitals in 90+ countries, Circle drives better outcomes through innovation. Learn more at www.circlecvi.com.